European Neurological Disorder Drugs Market Trends, Size, Competitive Analysis aPosted by mansi on November 9th, 2020 The European neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). The key factors that primarily flourish the growth of the market include the rising geriatric population along with the rising prevalence of neurological disorders. As per the European Academy of Neurology 2019, around 60% of the population suffers from any one of the neurological disorders, and there is an increased burden of deaths and cases of neurological diseases. Request a Free Sample of our European Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/european-neurological-disorder-drugs-market The European Academy of Neurology divided Europe into five major regions, which include, European Union (EU28), Western Europe, Central Europe, Eastern Europe, and WHO region Europe. The prevalence of neurological disorders in the EU28 is 307 million in which there were more than 1.1 million mortalities; the prevalence in Western Europe was 260 million with 0.8 million mortalities, and Central Europe has a prevalence of 67 million with 0.3 million mortalities. While Eastern Europe with a prevalence of 130 million and 0.6 mortalities, while the WHO region Europe has a total prevalence of 542 million with more than 1.9 million mortalities. Such an increased prevalence of disorders among the people in the region is the primary factor creating scope for the European neurological disorder drugs industry growth over the forecast period. A full Report of European Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/european-neurological-disorder-drugs-market Besides, the presence of the key players also supports the growth of the European neurological disorder drugs market. Players such as Novartis International AG, Allergan Plc., AstraZeneca Plc, and Boehringer Ingelheim International GmbH are significantly contributing to the market growth. Market Coverage
Key questions addressed by the report
o Recovery Timeline o Deviation from the pre-COVID-19 forecast o Most affected segment
Europe Neurological Disorder Drugs Market – Segmentation By Disorder Type
Europe Neurological Disorder Drugs Market – Countries Covered
Company Profiles
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404 Like it? Share it! More by this author |